These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 24236720)

  • 1. Computational medicinal chemistry for rational drug design: Identification of novel chemical structures with potential anti-tuberculosis activity.
    Koseki Y; Aoki S
    Curr Top Med Chem; 2014; 14(1):176-88. PubMed ID: 24236720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis: An Inorganic Medicinal Chemistry Perspective.
    Viganor L; Skerry C; McCann M; Devereux M
    Curr Med Chem; 2015; 22(18):2199-224. PubMed ID: 25850770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.
    Cooper CB
    J Med Chem; 2013 Oct; 56(20):7755-60. PubMed ID: 23927683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sawicki R; Ginalska G
    Future Med Chem; 2019 Aug; 11(16):2193-2203. PubMed ID: 31538522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model to predict anti-tuberculosis activity: value proposition for marine microorganisms.
    Liu M; Grkovic T; Zhang L; Liu X; Quinn RJ
    J Antibiot (Tokyo); 2016 Aug; 69(8):594-9. PubMed ID: 27406906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacology-Driven Discovery and Design of Highly Selective, Dual and Multitargeting Inhibitors of
    Amandy FV; Neri GLL; Manzano JAH; Go AD; Macabeo APG
    Curr Drug Targets; 2024; 25(9):620-634. PubMed ID: 38859782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update.
    De Leon Rodriguez LM; Kaur H; Brimble MA
    Org Biomol Chem; 2016 Jan; 14(4):1177-87. PubMed ID: 26645944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS; Rather MA; Maqbool M; Ahmad Z
    Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico approaches and chemical space of anti-P-type ATPase compounds for discovering new antituberculous drugs.
    Santos P; López-Vallejo F; Soto CY
    Chem Biol Drug Des; 2017 Aug; 90(2):175-187. PubMed ID: 28111912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents.
    Yan M; Xu L; Wang Y; Wan J; Liu T; Liu W; Wan Y; Zhang B; Wang R; Li Q
    Drug Dev Res; 2020 Jun; 81(4):402-418. PubMed ID: 31904877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB.
    de Souza MVN; Nogueira TCM
    Curr Top Med Chem; 2019; 19(8):567-578. PubMed ID: 30834835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors.
    Yang L; Hu X; Chai X; Ye Q; Pang J; Li D; Hou T
    Drug Discov Today; 2022 Jan; 27(1):326-336. PubMed ID: 34537334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.